Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease

In December, 2021 at the IXth All-Russian Congress «Pulmonary Hypertension 2021» the first Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart disease in adults were approved. The expert group discussed many contentious issues, including the...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	A. A. Shmalts, S. V. Gorbachevsky, T. V. Martynyuk, S. N. Nakonechnikov
Format:	Article
Sprog:	Russian
Udgivet:	InterMedservice 2022-10-01
Serier:	Евразийский Кардиологический Журнал
Fag:	pulmonary hypertension pulmonary arterial hypertension congenital heart disease vasoreactivity test
Online adgang:	https://www.heartj.asia/jour/article/view/6339

Lignende værker

Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension
af: Goncharova Natalia, et al.
Udgivet: (2025-01-01)

"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension
af: O V Sagaydak, et al.
Udgivet: (2016-06-01)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
af: Anton A. Shmalts, et al.
Udgivet: (2021-09-01)

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects
af: A. A. Shmalts, et al.
Udgivet: (2022-05-01)

The effects of oxygenation on acute vasodilator challenge in pulmonary arterial hypertension
af: Matthew D. Rockstrom, et al.
Udgivet: (2024-04-01)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
af: Nesrine Farhat, et al.
Udgivet: (2019-07-01)

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study
af: Mario Naranjo, et al.
Udgivet: (2023-07-01)

Usefulness of acute vasoreactivity testing to decide shunt closure
af: Despoina Ntiloudi, et al.
Udgivet: (2021-10-01)

Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
af: Sergey Y. Yarovoy, et al.
Udgivet: (2020-10-01)

On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates
af: M. A. Bortsova, et al.
Udgivet: (2019-07-01)

Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: a case report
af: Murathan Küçük, et al.
Udgivet: (2017-07-01)

Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia
af: A. A. Shmalts, et al.
Udgivet: (2020-12-01)

Self-reported physician practices in pulmonary arterial hypertension: Diagnosis, assessment, and referral
af: Susan Polanco-Briceno, et al.
Udgivet: (2016-04-01)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
af: Qi-Xia Xu, et al.
Udgivet: (2017-01-01)

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
af: Robert P. Frantz, et al.
Udgivet: (2023-01-01)

Changing demographics of pulmonary arterial hypertension in congenital heart disease
af: B.J.M. Mulder
Udgivet: (2010-12-01)

Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
af: M. A. Gatzoulis, et al.
Udgivet: (2009-09-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
af: I. E. Chazova, et al.
Udgivet: (2022-05-01)

Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young
af: Katharina Meinel, et al.
Udgivet: (2020-12-01)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
af: Antonio Lopes, et al.
Udgivet: (2014-01-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
af: S. Ye. Gratsianskaya, et al.
Udgivet: (2017-12-01)

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey
af: Tanguy Dutilleux, et al.
Udgivet: (2023-05-01)

Pulmonary hypertension associated with congenital heart disease; clinical decision scenario
af: Ali A. Alakhfash, et al.
Udgivet: (2020-01-01)

Acute effect of inhaled Iloprost in children with pulmonary arterial hypertension associated with simple congenital heart defects
af: Li, Qiangqiang, et al.
Udgivet: (2018)

Impact of Pulmonary Artery Banding in Patients with Congenital Heart Disease and Pulmonary Hypertension
af: Han Zhang, et al.
Udgivet: (2024-07-01)

Initial experiences with the treatment of pulmonary arterial hypertension in congenital heart disease in Slovenia
af: Katja Prokšelj, et al.
Udgivet: (2013-04-01)

Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension
af: Andreas J. Rieth, et al.
Udgivet: (2022-03-01)

Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice
af: Svetlana E Gratsianskaya, et al.
Udgivet: (2019-09-01)

Congenital Heart Disease with Pulmonary Hypertension; Surgery or Medical Treatment?
af: Ahmad Mirdamadi, et al.
Udgivet: (2014-12-01)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
af: Bibhuti B. Das, et al.
Udgivet: (2020-09-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
af: S. Ye. Gratsianskaya, et al.
Udgivet: (2017-12-01)

Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges
af: George Giannakoulas, MD, PhD, et al.
Udgivet: (2016-07-01)

Pulmonary arterial hypertension associated with congenital heart disease
af: Michele D'Alto, et al.
Udgivet: (2012-12-01)

Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide
af: L. T. Domingo, et al.
Udgivet: (2022-12-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
af: S. E. Gratsianskaya, et al.
Udgivet: (2019-12-01)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
af: T.V. Martynyuk, et al.
Udgivet: (2018-04-01)

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review
af: Xiaoxian Deng, et al.
Udgivet: (2020-11-01)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
af: Li Gu, et al.
Udgivet: (2020-03-01)

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
af: I E Chazova, et al.
Udgivet: (2019-01-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
af: I. E. Chazova, et al.
Udgivet: (2024-03-01)